Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:33 PM
Ignite Modification Date:
2025-12-24 @ 4:33 PM
NCT ID:
NCT02247466
Eligibility Criteria:
Inclusion Criteria:
* Patients \> 18 years old
* Elective laparoscopic umbilical herniotomy, incisional herniotomy and linea alba - herniotomy
* Can read and understand Danish
* Informed consent
Exclusion Criteria:
* Known allergy to sugammadex, rocuronium or mivacurium
* Known homozygous variants in the butyrylcholinesterase gene
* Severe renal disease, defined by S-creatinine\> 0.200 mmol/L, GFR \< 30ml/min or hemodialysis)
* Neuromuscular disease that may interfere with neuromuscular data
* Lactating or pregnant (Women of child bearing potential must take a urine pregnancy test at the day of the operation. The test will be provided by the hospital staff).
* Indication for rapid sequence induction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02247466
Study Brief:
Protocol Section:
NCT02247466